Outcome of Triple Negative Breast Cancer(TNBC) as compared to other breast cancers in Bir Hospital, National Academy of Medical Sciences

Introduction: In Nepal, breast cancer is the second most common cancer accounting for a large number of deaths.The subtype Triple-negative breast cancer (TNBC) is linked to poor prognosis and is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal g...

Full description

Bibliographic Details
Published in:	Journal of Society of Surgeons of Nepal
Main Authors:	Anip Joshi, Sandhya Chapagain, Sangita Shrestha, Niliza Shakya, Prajjwol Luitel, Ishwari Rajbhandari, Sujan Shrestha, Jocelyn Lippey, Deependra Singh, Prathiksha Karthikeyan, Ian Tannock, Christopher Pyke
Format:	Article
Language:	English
Published:	Society of Surgeons of Nepal 2024-11-01
Subjects:	Breast cancer outcome TNBC
Online Access:	https://nepjol.info/index.php/JSSN/article/view/71278

Similar Items

Defining triple‐negative breast cancer with neuroendocrine differentiation (TNBC‐NED)
by: Sean M Hacking, et al.
Published: (2023-07-01)

Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC)
by: Aiswarya Chaudhuri, et al.
Published: (2022-04-01)

Antiproliferative effect of Saraca asoca methanol bark extract on triple negative breast cancer (TNBC)
by: Chennattu M. Pareeth, et al.
Published: (2024-03-01)

Differentiation of triple-negative breast cancer and benign breast lesions using multiparametric ultrasonography
by: Gumowska Magdalena, et al.
Published: (2025-09-01)

Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)
by: Soheila Montazersaheb, et al.
Published: (2024-08-01)

Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
by: Sunny Kumar, et al.
Published: (2023-07-01)

Characterization of Disseminated Tumor Cells (DTCs) in Patients with Triple-Negative Breast Cancer (TNBC)
by: Anne Eckardt, et al.
Published: (2025-06-01)

Germline TP53 and MSH6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study
by: Dandan Yi, et al.
Published: (2019-01-01)

IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells
by: Damiano Cosimo Rigiracciolo, et al.
Published: (2020-04-01)

The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer
by: Seyyed Asadolah Mousavi, et al.
Published: (2013-03-01)

The Assessment of Response to Adjuvant Chemotherapy with CMF in Triple Negative Breast Cancer
by: Seyyed AsadoLah Mousavi, et al.
Published: (2013-01-01)

Targeted therapy for breast cancer prevention
by: Petra eden Hollander, et al.
Published: (2013-09-01)

Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC)
by: Khashayar Yazdanpanah Ardakani, et al.
Published: (2025-07-01)

Prognostic and Clinical Significance of PD-L1, EGFR and Androgen Receptor (AR) Expression in Triple-Negative Breast Cancer (TNBC) Patients
by: Nataša Medić-Milijić, et al.
Published: (2024-05-01)

Distinct Classes of Flavonoids and Epigallocatechin Gallate, Polyphenol Affects an Oncogenic Mutant p53 Protein, Cell Growth and Invasion in a TNBC Breast Cancer Cell Line
by: Madhu Kollareddy, et al.
Published: (2021-04-01)

Identification of Immune-Related Risk Characteristics and Prognostic Value of Immunophenotyping in TNBC
by: Jiarong Yi, et al.
Published: (2021-10-01)

Moderate Exercise Modulates Tumor Metabolism of Triple-Negative Breast Cancer
by: Anderson Vulczak, et al.
Published: (2020-03-01)

TNBC Therapeutics Based on Combination of Fusarochromanone with EGFR Inhibitors
by: Natalie Carroll, et al.
Published: (2022-11-01)

The Roles of DNA Demethylases in Triple-Negative Breast Cancer
by: Shoghag Panjarian, et al.
Published: (2021-06-01)

The therapeutic role of γδT cells in TNBC
by: Wenjing Li, et al.
Published: (2024-06-01)

Impact of COVID-19 on Postgraduate Surgical Education: A Cross-Sectional Study
by: Anip Joshi, et al.
Published: (2024-11-01)

Clinical significance and expression of ALDH1 in triple-negative breast cancer
by: Yaoyao Yang, et al.
Published: (2025-10-01)

GluOC promotes proliferation and metastasis of TNBC through the ROCK1 signaling pathway
by: Jiaojiao Xu, et al.
Published: (2024-07-01)

Breast Cancer Treatments: Drugs Targeting the PI3K/AKT/mTOR Pathway, TNBC Therapy and Future Directions: A Review
by: Klaudia Dynarowicz, et al.
Published: (2025-10-01)

Patterns of distant metastases in patients with triple‐negative breast cancer—A population‐based study
by: Yang Gao, et al.
Published: (2023-09-01)

Triple-Negative Breast Cancer on the Rise: Breakthroughs and Beyond
by: Agelidis A, et al.
Published: (2025-06-01)

The application of exosomes in the treatment of triple-negative breast cancer
by: John W. Weaver, et al.
Published: (2022-11-01)

PLK1 and PARP positively correlate in Middle Eastern breast cancer and their combined inhibition overcomes PARP inhibitor resistance in triple negative breast cancer
by: Abdul K. Siraj, et al.
Published: (2024-01-01)

BUB1 Inhibition Sensitizes TNBC Cell Lines to Chemotherapy and Radiotherapy
by: Sushmitha Sriramulu, et al.
Published: (2024-05-01)

Immune Landscape of Breast Cancers
by: Divya Nagarajan, et al.
Published: (2018-02-01)

Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer
by: Parijat Senapati, et al.
Published: (2019-07-01)

MFUM-BrTNBC-1, a Newly Established Patient-Derived Triple-Negative Breast Cancer Cell Line: Molecular Characterisation, Genetic Stability, and Comprehensive Comparison with Commercial Breast Cancer Cell Lines
by: Kristijan Skok, et al.
Published: (2021-12-01)

Liquid biopsy in TNBC: significance in diagnostics, prediction, and treatment monitoring
by: Jiayi Sheng, et al.
Published: (2025-08-01)

Surgical outcomes following neoadjuvant chemotherapy with and without immunotherapy in patients with triple-negative breast cancer
by: Anouchka Coste Holt, et al.
Published: (2024-09-01)

Evaluation of tumor-infiltrating lymphocytes (TILs) in molecular subtypes of an Indian cohort of breast cancer patients
by: Pooja M. Vaid, et al.
Published: (2022-11-01)

Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance
by: Hyungjoo Kim, et al.
Published: (2022-05-01)

Potensi nanopartikel chitosan berbasis flavonoid fisetin dari buah stroberi (Fragaria x ananassa): modalitas terapi dalam penatalaksanaan TNBC
by: Felicia Puspita Sari, et al.
Published: (2021-06-01)

MYC-Driven Pathways in Breast Cancer Subtypes
by: Yassi Fallah, et al.
Published: (2017-07-01)

PTPN2 inhibits TG-induced ERS-initiated TNBC apoptosis through the mitochondrial pathway
by: Yanhe An, et al.
Published: (2025-06-01)

Unraveling the protein kinase C/NDRG1 signaling network in breast cancer
by: C. Saponaro, et al.
Published: (2024-12-01)